What is the appropriate treatment for persistent vomiting in a patient with normal upper endoscopy and normal CT enterography?

Treatment of Persistent Vomiting with Normal Endoscopy and CT Enterography

When structural causes have been excluded by normal endoscopy and CT enterography, persistent vomiting should be treated with a systematic, multi-mechanistic antiemetic approach starting with dopamine antagonists (metoclopramide or haloperidol) or phenothiazines (prochlorperazine), administered around-the-clock rather than as-needed, with sequential addition of agents from different drug classes if symptoms persist.

Initial Diagnostic Considerations

Before initiating treatment, you must systematically exclude non-structural causes that normal endoscopy and CT enterography cannot detect:

• Medication review: Opioids, chemotherapy agents, and numerous other medications cause vomiting
• Metabolic abnormalities: Check electrolytes, glucose, calcium, thyroid function, and consider Addison's disease or hepatic porphyria 1
• CNS pathology: Any neurologic symptoms warrant brain imaging 1
• Functional disorders: Consider gastroparesis (gastric emptying study), cyclic vomiting syndrome, or cannabinoid hyperemesis syndrome 2, 3
• Cannabis use patterns: Distinguish between occasional use (may be therapeutic in CVS) versus heavy daily use for >1 year (suggests cannabinoid hyperemesis syndrome) 2

Critical pitfall: Gastric emptying scans should NOT be performed during active vomiting episodes or in patients using cannabis or opiates, as results are uninterpretable 3.

First-Line Pharmacologic Treatment

Start with scheduled (not PRN) dosing of one agent from these classes 1, 4:

Dopamine Antagonists (Preferred Initial Choice)

• Metoclopramide: 10-20 mg PO/IV every 4-6 hours 5, 1
• Haloperidol: 0.5-2 mg PO/IV every 4-6 hours 5, 1

Phenothiazines (Alternative First-Line)

• Prochlorperazine: 10 mg PO/IV every 6 hours or 25 mg suppository every 12 hours 5, 1
• Promethazine: 12.5-25 mg PO/IV every 4-6 hours or 25 mg suppository every 6 hours 5, 2

Route selection: If oral route is compromised by vomiting, use IV or rectal formulations 6, 7.

Sequential Escalation Strategy

If symptoms persist after 1 week of scheduled first-line therapy, add agents from different mechanistic classes rather than switching 1:

Add Serotonin (5-HT3) Antagonists

• Ondansetron: 8 mg PO/IV every 8 hours or 16-24 mg daily 5, 1
• Granisetron: 1-2 mg PO daily or 1 mg IV daily 5, 1

These have lower CNS side effects and provide synergistic benefit when combined with dopamine antagonists 1.

Consider Adding Corticosteroids

• Dexamethasone: 12 mg PO/IV daily 5, 7

Particularly effective when combined with metoclopramide and ondansetron 1.

Advanced/Refractory Treatment Options

For persistent symptoms despite multi-drug therapy, consider 5, 1, 4:

Atypical Antipsychotics (Category 1 Evidence)

• Olanzapine: 5-10 mg PO daily 5, 1
  • Especially helpful if bowel obstruction suspected 1

Anticholinergics

• Scopolamine: 1.5 mg transdermal patch every 72 hours 5, 1

Cannabinoids (FDA-approved for refractory cases)

• Dronabinol: 5-10 mg PO every 4-6 hours 5, 1
• Nabilone: 1-2 mg PO twice daily 5, 1

Anxiolytics (if anxiety component)

• Lorazepam: 0.5-2 mg PO/SL/IV every 6 hours 5, 7, 2

Supportive Management

Concurrent with pharmacotherapy 6, 7:

• Ensure adequate hydration and correct electrolyte abnormalities
• Consider proton pump inhibitors or H2 blockers if dyspepsia present (patients may confuse heartburn with nausea) 7, 4
• Small, frequent meals and avoidance of trigger foods 8

Key Clinical Pitfalls

1. PRN dosing fails: Around-the-clock scheduled dosing is essential for persistent vomiting 1, 6, 7
2. Single-agent approach: Refractory symptoms require multi-mechanistic targeting, not dose escalation of one agent 1
3. Overlooking constipation: This commonly causes or exacerbates nausea/vomiting, especially with opioid use 1
4. Missing cyclic vomiting syndrome: Requires 6 months cannabis cessation (or 3 typical cycle lengths) to definitively exclude cannabinoid hyperemesis syndrome 2
5. Repeated unnecessary imaging: Once structural causes excluded, avoid repeated endoscopy or imaging 2, 3

When to Reassess

If symptoms persist beyond 1 week of optimized multi-drug therapy 1:

• Reconsider the diagnosis (functional disorders, psychiatric causes)
• Evaluate for gastroparesis with gastric emptying study (if not already done and patient not on cannabis/opiates)
• Consider referral to gastroenterology or neurology depending on symptom pattern
• For truly refractory cases, specialized palliative care consultation may be warranted 4